Trial Profile
Retrospective study of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angiomyolipoma
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2018 New trial record